Prediction model of hepatocellular carcinoma risk in Asian patients with chronic hepatitis B treated with entecavir-Reference-Cited by-同舟云学术

Prediction model of hepatocellular carcinoma risk in Asian patients with chronic hepatitis B treated with entecavir

Published:2017-09-28 Issue:54 Volume:8 Page:92431-92441
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Chen Chien-Hung¹,Lee Chuan-Mo¹,Lai Hsueh-Chou²,Hu Tsung-Hui¹,Su Wen-Pang²,Lu Sheng-Nan¹,Lin Chia-Hsin²,Hung Chao-Hung¹,Wang Jing-Houng¹,Lee Mei-Hsuan³,Peng Cheng-Yuan²⁴

Affiliation:

1. Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan

2. Division of Hepatogastroenterology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan

3. Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan

4. School of Medicine, China Medical University, Taichung, Taiwan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease modifiers and novel markers in HBV-related HCC;Journal of Liver Cancer;2024-08-05

2. Mac-2 binding protein glycosylation isomer at 5 years of antiviral therapy predict hepatocellular carcinoma and mortality beyond year 5 in chronic hepatitis B patients with cirrhosis;American Journal of Cancer Research;2024

3. Comparative effectiveness of tenofovir versus entecavir in patients with hepatitis B virus-related cirrhosis in Taiwan: a retrospective cohort study;Frontiers in Pharmacology;2023-12-19

4. Survival prediction model with lion optimization for Hepatitis-B patients using supervised and unsupervised learning algorithm;Measurement: Sensors;2023-12

5. HCC prediction models in chronic hepatitis B patients receiving entecavir or tenofovir: a systematic review and meta-analysis;Virology Journal;2023-08-15